Health Canada says there is no evidence that using Tylenol during pregnancy can cause autism or other neurological disorders in children.
It said its advice was based on “robust, rigorous assessments of the available scientific evidence,” adding any new evidence would be “carefully evaluated.”
The FDA notified U.S. doctors on Sept. 22 that using acetaminophen during pregnancy may come with an increased risk of neurological conditions.
The FDA said it was also requiring an update label for acetaminophen, which will include the information about a link between the drug and autism.
Health Canada said it still recommends acetaminophen as a pain or fever treatment for pregnant women, adding that the medication has been “used safely by millions of Canadians for decades,” including during pregnancy and while breastfeeding.
It advised patients to use the “lowest effective dose” for the “shortest duration.”
The organization said that untreated fever and pain for a pregnant woman can cause risks to the unborn child.
Pregnant women who have concerns are advised to talk to their health care provider, it said.
Health Canada said it monitors the safety of all authorized medicines and if new scientific evidence demonstrated a risk, it would take action to update labels, inform health care professionals, and provide advice to Canadians.
A spokesperson for Tylenol’s parent company, Kenvue, previously told The Epoch Times in an email that they disagreed with the FDA’s position.
“We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers,” it said.







